Cargando…

Are EMS bypass policies effective implementation strategies for intravenous alteplase for stroke?

BACKGROUND: Stroke is a leading cause of disability and the fifth leading cause of death in the USA. Intravenous alteplase is a highly effective clot-dissolving stroke treatment that must be given in a hospital setting within a time-sensitive window. To increase the use of intravenous alteplase in s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Alex H. S., Barreto, Nicolas B., Trickey, Amber W., Bereknyei, Sylvia, Meng, Tong, Wagner, Todd H., Govindarajan, Prasanthi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427915/ https://www.ncbi.nlm.nih.gov/pubmed/32885206 http://dx.doi.org/10.1186/s43058-020-00041-5

Ejemplares similares

Lessons Learned From the Historical Trends on Thrombolysis Use for Acute Ischemic Stroke Among Medicare Beneficiaries in the United States
por: Meng, Tong, et al.
Publicado: (2022)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke
por: Chalos, Vicky, et al.
Publicado: (2019)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Tutorial: implementing and visualizing machine learning (ML) clinical prediction models into web-accessible calculators using Shiny R
por: Eddington, Hyrum S., et al.
Publicado: (2022)

Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
por: Chen, Jigang, et al.
Publicado: (2023)

Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms
por: Urrutia, Victor C., et al.
Publicado: (2018)

No sex difference was found in the safety and efficacy of intravenous alteplase before endovascular therapy
por: Fang, Min, et al.
Publicado: (2022)

Normal Appearing Ischaemic Brain Tissue on CT and Outcome After Intravenous Alteplase
por: Mair, Grant, et al.
Publicado: (2022)

Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients
por: Salem, Gelan M., et al.
Publicado: (2021)

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Role of intravenous alteplase on late lesion growth and clinical outcome after stroke treatment
por: Konduri, Praneeta, et al.
Publicado: (2023)

Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
por: Nie, Ximing, et al.
Publicado: (2021)

Safety and Efficacy of Intravenous Alteplase before Endovascular Thrombectomy: A Pooled Analysis with Focus on the Elderly
por: Honig, Asaf, et al.
Publicado: (2022)

Benefit and risk of intravenous alteplase in patients with acute large vessel occlusion stroke and low ASPECTS
por: Broocks, Gabriel, et al.
Publicado: (2023)

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Intravenous lidocaine as a non-opioid adjunct analgesic for traumatic rib fractures
por: Choi, Jeff, et al.
Publicado: (2020)

Impact of intravenous alteplase on sub-angiographic emboli in high-resolution diffusion-weighted imaging following successful thrombectomy
por: Broocks, Gabriel, et al.
Publicado: (2021)

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
por: Tan, Ge, et al.
Publicado: (2017)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Impact of Intravenous Alteplase Door-to-Needle Times on 2-Year Mortality in Patients With Acute Ischemic Stroke
por: Bhatt, Nirav R., et al.
Publicado: (2021)

Effect of Intravenous Alteplase on Functional Outcome and Secondary Injury Volumes in Stroke Patients with Complete Endovascular Recanalization
por: Broocks, Gabriel, et al.
Publicado: (2022)

Low-dose vs. standard-dose intravenous alteplase for acute ischemic stroke with unknown time of onset
por: Wang, Zekun, et al.
Publicado: (2023)

Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2021)

A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration
por: Harris, Dustin, et al.
Publicado: (2018)

Spontaneous Splenic Rupture Following Intravenous Thrombolysis with Alteplase Applied as Stroke Therapy – Case Report and Review of Literature
por: Aleksic-Shihabi, Anka, et al.
Publicado: (2016)

Effects of intravenous thrombolysis with alteplase combined with edaravone on cerebral hemodynamics and T lymphocyte level in patients with acute cerebral infarction
por: Li, Xiu-Xiu, et al.
Publicado: (2020)

Effect of intravenous thrombolysis with alteplase on clinical efficacy, inflammatory factors, and neurological function in patients with acute cerebral infarction
por: Wang, Jinhua, et al.
Publicado: (2021)

Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke
por: Li, Hongfei, et al.
Publicado: (2022)

Predicting prognosis in patients with stroke treated with intravenous alteplase through the 24‐h trajectory of blood pressure changes
por: Fan, Kaiting, et al.
Publicado: (2021)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

Association between computed tomography perfusion and the effect of intravenous alteplase prior to endovascular treatment in acute ischemic stroke
por: Hoving, Jan W., et al.
Publicado: (2023)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Shen, Ziyi, et al.
Publicado: (2023)

Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis
por: Huang, Pan, et al.
Publicado: (2023)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

Utilization of alteplase in trauma victim with an open abdomen
por: Martin, Sharolyn L, et al.
Publicado: (2011)

Effects of alteplase in the treatment of acute ischemic stroke
por: Yayan, Josef
Publicado: (2012)

Effect of alteplase on platelet function and receptor expression
por: Lu, Jun, et al.
Publicado: (2019)

Alteplase/epoprostenol: Lack of efficacy: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mfofcar0larsemr1bfjrhd0629